MACUSTAR: Development and clinical validation of functional, structural and patient-reported endpoints in intermediate age-related macular degeneration
MACUSTAR: Development and clinical validation of functional, structural and patient-reported endpoints in intermediate age-related macular degeneration
Robert P. Finger, Steffen SchmitzValckenberg, Matthias Schmid, Gary S. Rubin, Hannah Dunbar, Adnan Tufail, David P. Crabb, Alison Binns, Clara I. Sánchez, Philippe Margaron, Guillaume Normand, Mary Durbin, Ulrich Luhmann, Parisa Zamiri, José Cunha-Vaz, Friedrich Asmus, Frank G. Holz, Jan Henrik Terheyden
Ophthalmologica. 2019;241(2):61-72. doi: 10.1159/000491402. Epub 2018 Aug 28. Review.
2019
Systemic and Ocular Determinants of Peripapillary Retinal Nerve Fiber Layer Thickness Measurements in the European Eye Epidemiology (E3) Population.
Systemic and Ocular Determinants of Peripapillary Retinal Nerve Fiber Layer Thickness Measurements in the European Eye Epidemiology (E3) Population.
Mauschitz M, Bonnemaijer P, Diers K, Rauscher F, Elze T, Engel C, Loeffler M, Colijn J, Ikram MA, Vingerling J, Williams K, Hammond C, Creuzot-Garcher C, Bron A, MD, Silva R, Nunes S, Delcourt C, Cougnard-Grégoire A, Holz F, Klaver C, Breteler M, Finger R, on behalf of the European Eye Epidemiology(E3) Consortium.
Ophthalmology. 2018 Apr 28. pii: S0161-6420(17)33477-2. doi: 10.1016/j.ophtha.2018.03.026
2018
Changes in intraocular pressure after intravitreal fluocinolone acetonide (ILUVIEN): real-world experience in three European countries
Changes in intraocular pressure after intravitreal fluocinolone acetonide (ILUVIEN): real-world experience in three European countries
Usha Chakravarthy, Simon R Taylor, Frank H Johannes Koch, João Paulo Castro de Sousa, Clare Bailey
Br J Ophthalmol 2018;0:1-doi.org/10.1136/bjophthalmol-2018-312284
2018
Methodologic assessment of the systematic reviews of ophthalmic adverse drug reactions published in Ophthalmology journals: a systematic review
Methodologic assessment of the systematic reviews of ophthalmic adverse drug reactions published in Ophthalmology journals: a systematic review
Penedones A, Batel-Marques F
PURPOSE:
This systematic review aims to characterize and review the methodology of the systematic reviews reporting ophthalmic adverse drug reactions.
METHODS:
This systematic review followed the Cochrane Collaboration and the Preferred Reporting Items for Systematic Reviews and Meta-analyses guide. MEDLINE and EMBASE databases were searched, by all Ophthalmology journals. All systematic reviews reporting ophthalmic adverse drug reactions in the last decade were included. Data on methodology were extracted. Methodological quality was assessed through A MeaSurement Tool to Assess systematic Reviews 2 scale. Descriptive analysis was performed.
RESULTS:
Twenty-one systematic reviews were identified. Almost 60% of the systematic reviews reported non-ophthalmic drugs. Nine (43%) systematic reviews did not follow any recommendation. A search filter was not applied in 48% systematic reviews. Observational data was the source of information most included. The methodological quality was assessed in 57% systematic reviews. A meta-analysis was performed in 57% systematic reviews. The protocol’s elaboration, the explanation of the sources of information and the list of excluded articles were the domains less performed in the systematic reviews.
CONCLUSION:
The systematic reviews reporting ophthalmic adverse drug reactions diverged in some methodological aspects. Such an issue deserves further investigation, since discrepancies may lead to biased conclusions and, consequently, impact clinical and/or regulatory decisions.
Ophthalmic Res. 2018;60(2):55-68. doi: 10.1159/000489932.
2018
https://www.ncbi.nlm.nih.gov/pubmed/29975961
Drug-induced hypersensitivity: a 5-year retrospective study in a hospital electronic health records database
Drug-induced hypersensitivity: a 5-year retrospective study in a hospital electronic health records database
Mendes D, Alves C, Loureiro M, Fonte A, Batel Marques F
Journal of Clinical Pharmacy and Therapeutics
2018
Noninvasive Multimodal Imaging of Diabetic Retinopathy.
Noninvasive Multimodal Imaging of Diabetic Retinopathy.
Marques I, Mendes L, Cunha-Vaz J
In: Imaging Techniques. ESASO Course Series. Cunha-Vaz J, Koh A (eds): Basel, Karger, 2018, vol 10, pp 88-101. https://doi.org/10.1159/000487414
2018
Quantification of Retinal Microvascular Density in Optical Coherence Tomography Angiography Images in Diabetic Retinopathy.
Quantification of Retinal Microvascular Density in Optical Coherence Tomography Angiography Images in Diabetic Retinopathy.
Durbin MK, An L, Shemonski DS, Soares M, Santos T, Lopes M, Neves C, Cunha-Vaz J.
JAMA Ophthalmol. 2017;135(4):370-376.
2017
OCT-Leakage mapping. A new automated method of OCT data analysis to identify and locate abnormal fluid in retinal edema
OCT-Leakage mapping. A new automated method of OCT data analysis to identify and locate abnormal fluid in retinal edema
Farinha C, Santos T, Marques IP, Marques JP, Ribeiro L, Figueira J, Silva R, Cunha-Vaz J
Ophthalmology Retina 2017;1:486-496.
2017
Functional and Structural Findings of Neurodegeneration in Early Stages of Diabetic Retinopathy: Cross-sectional Analyses of Baseline Data of the EUROCONDOR Project.
Functional and Structural Findings of Neurodegeneration in Early Stages of Diabetic Retinopathy: Cross-sectional Analyses of Baseline Data of the EUROCONDOR Project.
Santos AR, Ribeiro L, Bandello F, Lattanzio R, Egan C, Frydkjaer-Olsen U, García-Arumí J, Gibson J, Grauslund J, Harding SP, Lang GE, Massin P, Midena E, Scanlon P, Aldington SJ, Simão S, Schwartz C, Ponsati B, Porta M, Costa MÂ, Hernández C, Cunha-Vaz J, Simó R; European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR).
Diabetes. 2017 Sep;66(9):2503-2510.
2017
Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study).
Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study).
Figueira J, Fletcher E, Massin P, Silva R, Bandello F, Midena E, Varano M, Sivaprasad S, Eleftheriadis H, Menon G, Amaro M, Ayello Scheer S, Creuzot-Garcher C, Nascimento J, Alves D, Nunes S, Lobo C, Cunha-Vaz J; EVICR.net Study Group.
Ophthalmology. 2018 May;125(5):691-700.
2018
